Contrasting BR Biopharma (NASDAQ:BRBI) and Greenpro Capital (NASDAQ:GRNQ)

Greenpro Capital (NASDAQ:GRNQ) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

Insider & Institutional Ownership

0.9% of Greenpro Capital shares are owned by institutional investors. 20.0% of Greenpro Capital shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings for Greenpro Capital and BR Biopharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenpro Capital	1	0	0	0	1.00
BR Biopharma	1	0	0	0	1.00

Earnings & Valuation

This table compares Greenpro Capital and BR Biopharma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenpro Capital	$2.00 million	7.12	-$2.98 million	($3.60)	-2.18
BR Biopharma	$2.23 billion	0.06	$31.36 million	$0.08	141.55

BR Biopharma has higher revenue and earnings than Greenpro Capital. Greenpro Capital is trading at a lower price-to-earnings ratio than BR Biopharma, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Greenpro Capital and BR Biopharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Greenpro Capital	-169.65%	-22.06%	-18.90%
BR Biopharma	N/A	N/A	N/A

Summary

BR Biopharma beats Greenpro Capital on 7 of the 10 factors compared between the two stocks.

About Greenpro Capital

Greenpro Capital Corp. provides financial consulting and corporate advisory services to small and medium-size businesses primarily in Hong Kong, Malaysia, and China. It operates in two segments, Service Business and Real Estate Business. The company offers business consulting and corporate advisory services, including cross-border listing advisory, tax planning, bookkeeping, advisory and transaction, record management, and accounting outsourcing services; and venture capital related education and support services. It is also involved in the acquisition and rental of real estate properties held for investment and sale; and provision of company formation advisory, company secretarial, and financial services. In addition, the company provides corporate advisory services, such as company review, bank loan advisory, and bank products analysis, as well as loan and credit, and insurance brokerage services; and wealth planning, administration, charity, tax and legal, trusteeship and risk management, investment planning and management, and business support services, as well as asset protection and management, consolidation, and performance monitoring services. The company was formerly known as Greenpro, Inc. and changed its name to Greenpro Capital Corp. in May 2015. Greenpro Capital Corp. was incorporated in 2013 and is headquartered in Kuala Lumpur, Malaysia.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.